Routine oxytocin in the third stage of labour: A placebo controlled randomised trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 7, 1997, Pages 781-786

  Nordström, Lennart ^a   Fogelstam, Kerstin ^a   Fridman, Gunilla ^a   Larsson, Anita ^a   Rydhstroem, Hakan ^b  

^a Department of Obstetrics and Gynaecology   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLERGOMETRINE; OXYTOCIN; PLACEBO;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LABOR; MACROSOMIA; MAJOR CLINICAL STUDY; META ANALYSIS; NUTRITIONAL STATUS; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; VAGINAL DELIVERY;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; LABOR STAGE, THIRD; LENGTH OF STAY; OXYTOCIN; PLACENTA, RETAINED; POSTPARTUM HEMORRHAGE; PREGNANCY; RECURRENCE; TREATMENT OUTCOME;

EID: 0030855783     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb12020.x     Document Type: Article

References (13)

1. Dudley HW, Moir JC. The substance responsible for the traditional clinical effect of ergot. BMJ 1935; 1: 520-523.
2. Moir JC. The history of present day use of ergot. Can Med Assoc J 1955; 72: 727-734.
3. Prendiville W, Elbourne D, Chalmers I. The effect of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988; 95:3-16.
4. Howard WF, McFadden PR, Keettel WC. Oxytoxic drugs in fourth stage of labor. JAMA 1964; 189:411-413.
5. Daley D. The use of intramuscular ergometrine at the end of the second stage of normal labour. J Obstet Gynaecol Br Emp 1951; 58: 388-397.
6. Rooney I, Hughes P, Calder A. Is routine administration of syntometrine still justified in the management of the third stage of labour Health Bull 1985; 43:99-101.
7. Yuen PM, Chan NST, Yim SF, Chang AMZ. A randomised double blind comparison of Syntometrine and Syntocinon in the management of the third stage of labour. Br J Obstet Gynaecol 1995; 102: 377-380.
8. McDonald SJ, Prendiville WJ, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active manage- ment of third stage of labour. BMJ 1993; 307: 1167-1171.
9. Thilaganathan B, Cuter A, Latimer J, Beard R. Management of the third stage of labour in women at low risk of postpartum haemmorrhage. Eur J Obstet Gynecol Reprod Biol 1993; 48: 19-22.
10. Miettinen O. Simple interval estimation of risk ratio. Am J Epidemiol 1974; 100: 515-516.
11. Chatellier G, Zapletal E, Lemaitre D, Menard J, Degoulet P. The numbers needed to treat: a clinically useful nomogram in its proper context. BMJ 1996; 312:426-429.
12. Elbourne D, Prendiville W, Chalmers I. Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Ohstet Gynaecol 1988; 95: 17-30.
13. Embrey MP. Simultaneous intramuscular injection of oxytocin and ergometrine: A tocographic study. BMJ 1961; 1: 1737-1738.